Literature DB >> 21412796

Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type.

Heli Harvala1, Nigel McLeish, Jasmina Kondracka, Chloe L McIntyre, E Carol McWilliam Leitch, Kate Templeton, Peter Simmonds.   

Abstract

Human enteroviruses (EVs) and more recently parechoviruses (HPeVs) have been identified as the principal viral causes of neonatal sepsis-like disease and meningitis. The relative frequencies of specific EV and HPeV types were determined over a 5-year surveillance period using highly sensitive EV and HPeV PCR assays for screening 4,168 cerebrospinal fluid (CSF) specimens collected from hospitalized individuals between 2005 and 2010 in Edinburgh. Positive CSF samples were typed by sequencing of VP1. From the 201 EV and 31 HPeV positive (uncultured) CSF samples on screening, a high proportion of available samples could be directly typed (176/182, 97%). Highest frequencies of EV infections occurred in young adults (n = 43; 8.6%) although a remarkably high proportion of positive samples (n = 98; 46%) were obtained from young infants (<3 months). HPeV infections were seen exclusively in children under the age of 3 months (31/1,105; 2.8%), and confined to spring on even-numbered years (22% in March 2006, 25% in April 2008, and 22% in March 2010). In contrast, EV infections were distributed widely across the years. Twenty different EV serotypes were detected; E9, E6, and CAV9 being found most frequently, whereas all but one HPeVs were type 3. Over this period, HPeV3 was identified as the most prevalent picornavirus type in CNS-related infections with similarly high incidences of EV infection frequencies in very young children. The highly sensitive virus typing methods applied in this study will assist further EV and HPeV screening of sepsis and meningitis cases as well as in future molecular epidemiological studies and population surveillance.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412796     DOI: 10.1002/jmv.22023

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  29 in total

1.  Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods.

Authors:  Nigel J McLeish; Jeroen Witteveldt; Lucy Clasper; Chloe McIntyre; E Carol McWilliam Leitch; Alison Hardie; Susan Bennett; Rory Gunson; William F Carman; Susan A Feeney; Peter V Coyle; Barry Vipond; Peter Muir; Kimberley Benschop; Katja Wolthers; Matti Waris; Riikka Osterback; Ingo Johannessen; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

Review 2.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

3.  Emergence of Parechovirus A4 Central Nervous System Infections among Infants in Kansas City, Missouri, USA.

Authors:  A Sasidharan; C J Harrison; D Banerjee; R Selvarangan
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

4.  Rapid simultaneous detection of enterovirus and parechovirus RNAs in clinical samples by one-step real-time reverse transcription-PCR assay.

Authors:  Susan Bennett; Heli Harvala; Jeroen Witteveldt; E Carol McWilliam Leitch; Nigel McLeish; Kate Templeton; Rory Gunson; William F Carman; Peter Simmonds
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  Environmental surveillance of human parechoviruses in sewage in The Netherlands.

Authors:  W J Lodder; M Wuite; A M de Roda Husman; S A Rutjes
Journal:  Appl Environ Microbiol       Date:  2013-08-09       Impact factor: 4.792

6.  Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria.

Authors:  Herbert Kurz; Ruth Prammer; Wolfgang Bock; Robert Ollerieth; Günther Bernert; Karl Zwiauer; Judith H Aberle; Stephan W Aberle; Tamas Fazekas; Wolfgang Holter
Journal:  Eur J Pediatr       Date:  2015-06-25       Impact factor: 3.860

7.  Characteristics and outcomes of human parechovirus infection in infants (2008-2012).

Authors:  Stefania Vergnano; Seilesh Kadambari; Katrina Whalley; Esse N Menson; Nuria Martinez-Alier; Mehrengise Cooper; Emile Sanchez; Paul T Heath; Hermione Lyall
Journal:  Eur J Pediatr       Date:  2015-01-10       Impact factor: 3.860

8.  Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications.

Authors:  Wei Xu; Chun-feng Liu; Li Yan; Jiu-jun Li; Li-jie Wang; Ying Qi; Rui-bo Cheng; Xiao-yu Xiong
Journal:  Virol J       Date:  2012-01-09       Impact factor: 4.099

9.  Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall, UK.

Authors:  Prithwiraj Chakrabarti; Chris Warren; Laura Vincent; Yadlapalli Kumar
Journal:  Eur J Pediatr       Date:  2018-07-18       Impact factor: 3.860

10.  Epidemic myalgia in adults associated with human parechovirus type 3 infection, Yamagata, Japan, 2008.

Authors:  Katsumi Mizuta; Makoto Kuroda; Masayuki Kurimura; Yoshikazu Yahata; Tsuyoshi Sekizuka; Yoko Aoki; Tatsuya Ikeda; Chieko Abiko; Masahiro Noda; Hirokazu Kimura; Tetsuya Mizutani; Takeo Kato; Toru Kawanami; Tadayuki Ahiko
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.